These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 679503)

  • 1. The effect of propranolol on thyroid hormones and oxygen consumption in thyrotoxicosis.
    Saunders J; Hall SE; Crowther A; Sönksen PH
    Clin Endocrinol (Oxf); 1978 Jul; 9(1):67-72. PubMed ID: 679503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of propranolol on circulating thyroid hormone measurements in thyrotoxic and euthyroid subjects.
    Franklyn JA; Wilkins MR; Wilkinson R; Ramsden DB; Sheppard MC
    Acta Endocrinol (Copenh); 1985 Mar; 108(3):351-5. PubMed ID: 3920853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroxine and triiodothyronine levels in hyperthyroid patients during treatment with propranolol.
    Harrower AD; Fyffe JA; Horn DB; Strong JA
    Clin Endocrinol (Oxf); 1977 Jul; 7(1):41-4. PubMed ID: 880733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of propranolol on thyroid hormones in T3 toxicosis.
    Jones MK; Owens DR; Jones GR; Birtwell J
    Clin Endocrinol (Oxf); 1981 Jun; 14(6):621-3. PubMed ID: 7296908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propranolol, triiodothyronine, reverse triiodothyronine and thyroid disease.
    Feely J; Isles TE; Ratcliffe WA; Crooks J
    Clin Endocrinol (Oxf); 1979 May; 10(5):531-8. PubMed ID: 476982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compared effect of propranolol and acebutolol on serum thyroid hormones' levels in euthyroid and hyperthyroid patients: a randomized study.
    Perret G; Hugues JN; Modigliani E; Sebaoun J
    Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):360-4. PubMed ID: 6469425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of propranolol withdrawal on thyroid hormones in normal and hyperthyroid subjects.
    Ross PJ; Jones MK; John R
    Clin Endocrinol (Oxf); 1980 Jul; 13(1):27-31. PubMed ID: 7438461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propranolol versus carbimazole as the sole treatment for thyrotoxicosis. A consideration of circulating thyroid hormone levels and tissue thyroid function.
    O'Malley BP; Abbott RJ; Barnett DB; Northover BJ; Rosenthal FD
    Clin Endocrinol (Oxf); 1982 Jun; 16(6):545-52. PubMed ID: 7105427
    [No Abstract]   [Full Text] [Related]  

  • 9. Preliminary report on the use of propranolol in thyrotoxicosis: I. Effect on serum thyroxine, triiodothyronine and reverse triiodothyronine concentrations.
    Tevaarwerk GJ; Malik MH; Boyd D
    Can Med Assoc J; 1978 Aug; 119(4):350-1, 360. PubMed ID: 688126
    [No Abstract]   [Full Text] [Related]  

  • 10. Propranolol influences serum T3 and reverse T3 in hyperthyroidism.
    Theilade P; Hansen JM; Skovsted L; Faber J; Kirkegård C; Friis T; Siersbaek-Nielsen K
    Lancet; 1977 Aug; 2(8033):363. PubMed ID: 69976
    [No Abstract]   [Full Text] [Related]  

  • 11. Propranolol in the treatment of thyrotoxicosis. A randomized double-blind study.
    Kvetny J; Frederikesen PK; Jacobsen JG; Haas V; Feldt-Rasmussen U; Date J
    Acta Med Scand; 1981; 209(5):389-92. PubMed ID: 7018181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative treatment of thyrotoxicosis with a beta-adrenergic blocking agent.
    Ljunggren JG; Persson B
    Acta Chir Scand; 1975; 141(8):715-8. PubMed ID: 3081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propranolol and hyperthyroidism: sequential changes in serum iodothyronine (T4, T3, rT3) concentrations during therapy until clinical remission.
    Pinho MO; Medeiros YS; Rosenthal D; Francalanci CC
    Braz J Med Biol Res; 1983 Jul; 16(2):111-7. PubMed ID: 6652288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of D- versus L-propranolol in the treatment of hyperthyroidism.
    Eber O; Buchinger W; Lindner W; Lind P; Rath M; Klima G; Langsteger W; Költringer P
    Clin Endocrinol (Oxf); 1990 Mar; 32(3):363-72. PubMed ID: 2344697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propranolol as primary therapy for thyrotoxicosis.
    Mazzaferri EL; Reynolds JC; Young RL; Thomas CN; Parisi AF
    Arch Intern Med; 1976 Jan; 136(1):50-6. PubMed ID: 1108824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of propranolol on serum levels of T4, T3 and reverse-T3 in hyperthyroidism.
    Kallner G; Ljunggren JG; Tryselius M
    Acta Med Scand; 1978; 204(1-2):35-7. PubMed ID: 685727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperthyroidism after propranolol withdrawal.
    Shenkman L; Podrid P; Lowenstein J
    JAMA; 1977 Jul; 238(3):237-9. PubMed ID: 577524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D-propranolol and DL-propranolol both decrease conversion of L-thyroxine to L-triiodothyronine.
    Heyma P; Larkins RG; Higginbotham L; Ng KW
    Br Med J; 1980 Jul; 281(6232):24-5. PubMed ID: 7407482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum T4, T3 and reverse T3 during treatment with propranolol in hyperthyroidism, L-T4 treated myxedema and in normal man.
    Faber J; Friis T; Kirkegaard C; Lumholtz IB; Hansen JM; Siersbaek-Nielsen K; Skovsted L; Theilade P
    Horm Metab Res; 1979 Jan; 11(1):34-6. PubMed ID: 428906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acetylation phenotype and serum levels of T3 and T4 in patients with hypertension treated with propranolol].
    Gasińska T; Nowak S; Wawrzyniak L; Widala E
    Endokrynol Pol; 1989; 40(6):301-6. PubMed ID: 2485732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.